Sunridge International, Inc. (SNDZ) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Sunridge International, Inc. (SNDZ) trades at $0.0001. Sunridge International, Inc. specializes in manufacturing and marketing patented vacuum fixation devices and suction rings for glaucoma treatment. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for SNDZ: SNDZ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SNDZ against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on SNDZ.
How is this calculated? →Sunridge International, Inc. (SNDZ) Healthcare & Pipeline Overview
Sunridge International, Inc. focuses on developing and distributing patented vacuum fixation devices for glaucoma treatment within the medical devices sector. The company's products cater to medical supply companies and healthcare providers, addressing a specific niche in ophthalmic surgical solutions amidst competitive pressures and evolving healthcare regulations.
What Is the Investment Thesis for SNDZ?
Sunridge International, Inc. presents a focused investment case centered on its patented vacuum fixation devices for glaucoma treatment. Key value drivers include the potential for increased adoption of its devices among ophthalmic surgeons and the expansion into new geographic markets. The company's high gross margin of 76.4% indicates strong pricing power. However, the company's negative profit margin of -691.1% and OTC market listing raise concerns about financial stability and liquidity. Growth catalysts include potential partnerships with larger medical device distributors and the development of next-generation surgical tools. Investors should carefully weigh the company's niche market position against its financial risks and competitive pressures before considering an investment.
Based on FMP financials and quantitative analysis
SNDZ Key Highlights
Gross margin of 76.4% indicates strong pricing power in its niche market.
- Specializes in patented vacuum fixation devices and suction rings for glaucoma treatment.
- Serves medical supply companies and healthcare providers globally.
- Market capitalization of $0.00B reflects its small size and potential volatility.
- Negative P/E ratio of -0.00 and profit margin of -691.1% signal financial challenges.
Who Are SNDZ's Competitors?
SNDZ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CNVIF Conavi Medical Corp. | $0.13 | -1.19% | $11.4M | 66 |
| VPTDF VentriPoint Diagnostics Ltd. | $0.07 | -4.02% | $13.8M | 62 |
| LHDX Lucira Health, Inc. | $0.45 | +0.00% | $18.4M | 64 |
| PLSM PLSM | $2.96 | -1.66% | $19.3M | 60 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.27 | -1.08% | $24.6M | 73 |
| RDGL Vivos Inc. | $0.05 | -5.33% | $26.5M | 61 |
| NVYTF Novacyt S.A. | $0.48 | -0.00% | $34.8M | 61 |
| DNAY Codex DNA, Inc. | $1.30 | +8.33% | $38.3M | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SNDZ's Key Strengths?
Patented technology in vacuum fixation devices.
- High gross margin (76.4%).
- Specialized focus on glaucoma treatment.
- Global distribution network.
What Are SNDZ's Weaknesses?
Negative profit margin (-691.1%).
- Small market capitalization ($0.00B).
- OTC market listing.
- Dependence on a niche market.
What Could Drive SNDZ Stock Higher?
Expansion into emerging markets to increase sales and market share.
- Development of next-generation vacuum fixation devices to enhance surgical outcomes.
- Strategic partnerships with medical device distributors to expand market reach.
What Are the Key Risks for SNDZ?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger medical device companies with greater resources.
- Stringent regulatory requirements and potential for delays in product approvals.
- Negative profit margin and financial instability.
- Limited liquidity due to OTC market listing.
- Shell risk detected.
What Are the Growth Opportunities for SNDZ?
- Expansion into Emerging Markets: Sunridge International can pursue growth by expanding its geographic presence in emerging markets with growing healthcare infrastructure and increasing prevalence of glaucoma. This includes regions in Asia-Pacific and Latin America, where the demand for advanced ophthalmic surgical devices is rising. Successful market entry requires strategic partnerships with local distributors and adaptation to local regulatory requirements. Timeline: Ongoing.
- Development of Next-Generation Devices: Investing in research and development to create next-generation vacuum fixation devices with enhanced features and improved surgical outcomes can drive growth. This includes incorporating advanced materials, ergonomic designs, and compatibility with minimally invasive surgical techniques. The company can collaborate with leading ophthalmic surgeons to gather feedback and refine its product development efforts. Timeline: Ongoing.
- Strategic Partnerships with Medical Device Distributors: Forming strategic partnerships with established medical device distributors can expand Sunridge International's market reach and access to healthcare providers. Distributors can leverage their existing networks and sales infrastructure to promote and sell the company's products in new geographic regions and healthcare settings. This includes partnering with distributors specializing in ophthalmic surgical devices. Timeline: Ongoing.
- Acquisition of Complementary Technologies: Sunridge International can explore opportunities to acquire complementary technologies or companies in the ophthalmic surgery space to broaden its product portfolio and enhance its competitive position. This includes acquiring companies with expertise in surgical instruments, imaging systems, or drug delivery technologies. Successful acquisitions require careful due diligence and integration planning. Timeline: Potential.
- Focus on Training and Education Programs: Providing comprehensive training and education programs for ophthalmic surgeons on the proper use of its vacuum fixation devices can drive adoption and improve surgical outcomes. This includes offering hands-on workshops, online training modules, and educational materials. The company can partner with leading ophthalmic training centers to deliver its programs. Timeline: Ongoing.
What Are SNDZ's Competitive Advantages?
- Patented technology in vacuum fixation devices.
- Specialized focus on glaucoma treatment.
- Established relationships with medical supply companies.
- Global distribution network.
What Does SNDZ Do?
Founded in 1997 and based in Fountain Hills, Arizona, Sunridge International, Inc. is a manufacturer and marketer of patented medical devices used in glaucoma surgery. The company's core products are vacuum fixation devices and suction rings, specifically designed for the treatment of open angle and pigmentary glaucoma. These devices aid surgeons in stabilizing the eye during delicate procedures, enhancing precision and control. Sunridge International operates by serving medical supply companies and healthcare providers directly. The company's market reach is global, distributing its products worldwide. Sunridge International, Inc. has established itself as a niche player within the broader medical devices industry, focusing on specialized ophthalmic surgical tools. The company's patented technology provides a degree of competitive advantage, though it must continually innovate to maintain its position against larger competitors with broader product portfolios.
What Products and Services Does SNDZ Offer?
- Manufactures patented vacuum fixation devices for glaucoma surgery.
- Produces suction rings used in ophthalmic procedures.
- Markets its products to medical supply companies.
- Serves healthcare providers specializing in glaucoma treatment.
- Distributes its devices worldwide.
- Focuses on devices for open angle and pigmentary glaucoma.
How Does SNDZ Make Money?
- Direct sales to medical supply companies.
- Sales to healthcare providers, including hospitals and surgical centers.
- Revenue generated from the sale of patented vacuum fixation devices and suction rings.
- Global distribution network.
What Industry Does SNDZ Operate In?
Sunridge International operates within the medical devices industry, specifically targeting the ophthalmic surgery segment. The global medical devices market is characterized by technological innovation, stringent regulatory requirements, and intense competition. The glaucoma treatment market is driven by the aging global population and increasing prevalence of the disease. Sunridge International's niche focus on vacuum fixation devices positions it as a specialized player, competing with larger companies offering a broader range of surgical solutions. The company's success depends on its ability to maintain its technological edge and navigate the complex regulatory landscape.
Who Are SNDZ's Key Customers?
- Medical supply companies.
- Hospitals.
- Surgical centers.
- Ophthalmic surgeons.
Financial Health
Sunridge International, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Key Financial Metrics
Return on equity for Sunridge International, Inc. stands at 251.4%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.25 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
Sunridge International, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Fountain Hills, US. The company is led by CEO G. Richard Smith. SNDZ has traded publicly since 2009.
SNDZ Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying may signal confidence in the company's future prospects, suggesting those with inside knowledge believe the stock is undervalued.
- Positive community sentiment indicates growing investor optimism regarding Sunridge International's potential growth and market position.
- Bullish community views highlight the company's innovative approach and potential to disrupt its industry.
- Market perception suggests Sunridge International is gaining recognition, possibly leading to increased investor interest and demand.
Bear Case
- Recent insider selling could indicate a lack of confidence in the company's short-term prospects or a need to liquidate holdings.
- Negative community sentiment reflects concerns about Sunridge International's ability to execute its business strategy effectively.
- Bearish community views point to potential challenges in the company's competitive landscape and its ability to maintain market share.
- Market perception suggests Sunridge International is facing headwinds, possibly due to regulatory issues or changing consumer preferences.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SNDZ Latest News
No recent news available for SNDZ.
SNDZ Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SNDZ.
Price Targets
Wall Street price target analysis for SNDZ.
SNDZ MoonshotScore
What does this score mean?
The MoonshotScore rates SNDZ 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: G. Richard Smith
CEO
G. Richard Smith serves as the Chief Executive Officer of Sunridge International, Inc. While detailed background information is limited, his role involves overseeing the company's strategic direction, managing operations, and driving growth. As CEO, he is responsible for guiding the company's efforts in manufacturing and marketing its patented vacuum fixation devices and suction rings for glaucoma treatment.
Track Record: Information regarding G. Richard Smith's specific achievements and milestones as CEO of Sunridge International, Inc. is not available. His leadership is focused on maintaining the company's position in the niche market of ophthalmic surgical devices and navigating the challenges of operating as a small company in a competitive industry.
SNDZ OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Sunridge International, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier typically signifies higher risk and requires increased due diligence from investors compared to stocks listed on national exchanges.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Shell risk detected.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's intellectual property and patent portfolio.
- Review the company's legal and regulatory compliance.
- Monitor trading volume and price volatility.
- Consult with a qualified financial advisor.
- Patented technology in vacuum fixation devices.
- Focus on a specific niche market (glaucoma treatment).
- Global distribution network.
- Established relationships with medical supply companies.
What Investors Ask About Sunridge International, Inc. (SNDZ) — Healthcare
What does Sunridge International, Inc. do?
Sunridge International, Inc. specializes in the development, manufacturing, and marketing of patented vacuum fixation devices and suction rings used in glaucoma surgery. These devices are designed to improve the precision and stability of surgical procedures for treating open angle and pigmentary glaucoma. The company serves medical supply companies and healthcare providers worldwide, focusing on providing specialized ophthalmic surgical solutions.
What do analysts say about SNDZ stock?
As of 2026-03-16, there is no readily available analyst coverage or consensus on Sunridge International, Inc. due to its OTC listing and small market capitalization. Key valuation metrics such as P/E ratio (-0.00) and profit margin (-691.1%) indicate financial challenges. Investors should conduct their own thorough research and consider the company's niche market position, growth potential, and financial risks before making any investment decisions.
What are the main risks for SNDZ?
Sunridge International, Inc. faces several risks, including intense competition from larger medical device companies, stringent regulatory requirements, and financial instability due to its negative profit margin. The company's OTC market listing and limited liquidity also pose risks for investors. Additionally, the detection of shell risk raises concerns about the company's legitimacy and potential for fraudulent activities. Investors should carefully assess these risks before considering an investment in SNDZ.
What are the key factors to evaluate for SNDZ?
Evaluate SNDZ on fundamentals, analyst consensus, and risk factors. Sunridge International, Inc. presents a focused investment case centered on its patented vacuum fixation devices for glaucoma treatment. Not financial advice.
How frequently does SNDZ data refresh on this page?
SNDZ's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven SNDZ's recent stock price performance?
Sunridge International, Inc. (SNDZ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Patented technology in vacuum fixation devices. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SNDZ overvalued or undervalued right now?
Sunridge International, Inc. (SNDZ) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research SNDZ before investing?
Before investing in Sunridge International, Inc. (SNDZ), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-listed companies.
- Financial data may not be fully up-to-date.